losmapimod   Click here for help

GtoPdb Ligand ID: 7835

Synonyms: GS856553 | GW856553
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: Losmapimod is a p38 mitogen-activated kinase α/β inhibitor. It was originally developed by GlaxoSmithKline for cardiovascular disease, but this failed to show efficacy. Fulcrum acquired the drug and are repurposing it for the treatment of the progressive muscle wasting disorder facioscapulohumeral muscular dystrophy (FSHD) based on evidence that p38α regulates expression of the FSHD-related gene DUX4 [4-5].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 2
Rotatable bonds 8
Topological polar surface area 71.09
Molecular weight 383.2
XLogP 4.01
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES O=C(c1ccc(nc1)c1cc(cc(c1C)F)C(=O)NC1CC1)NCC(C)(C)C
Isomeric SMILES O=C(c1ccc(nc1)c1cc(cc(c1C)F)C(=O)NC1CC1)NCC(C)(C)C
InChI InChI=1S/C22H26FN3O2/c1-13-17(9-15(10-18(13)23)21(28)26-16-6-7-16)19-8-5-14(11-24-19)20(27)25-12-22(2,3)4/h5,8-11,16H,6-7,12H2,1-4H3,(H,25,27)(H,26,28)
Classification Click here for help
Compound class Synthetic organic
IUPAC Name Click here for help
International Nonproprietary Names Click here for help
INN number INN
9118 losmapimod
Synonyms Click here for help
GS856553 | GW856553
Database Links Click here for help
CAS Registry No. 585543-15-3
ChEMBL Ligand CHEMBL1088752
GtoPdb PubChem SID 223366166
PubChem CID 11552706
Search Google for chemical match using the InChIKey KKYABQBFGDZVNQ-UHFFFAOYSA-N
Search Google for chemicals with the same backbone KKYABQBFGDZVNQ
Search PubMed clinical trials losmapimod
Search PubMed titles losmapimod
Search PubMed titles/abstracts losmapimod
UniChem Compound Search for chemical match using the InChIKey KKYABQBFGDZVNQ-UHFFFAOYSA-N
UniChem Connectivity Search for chemical match using the InChIKey KKYABQBFGDZVNQ-UHFFFAOYSA-N
Wikipedia Losmapimod